Skip to main content
. 2018 May 23;11:185–192. doi: 10.2147/CEG.S162703

Table 2.

Study population characteristics at initial presentation, including clinical features, laboratory values, time of presentation, and outcome variables (univariate analysis)

Population characteristics Total population (N=468) Patients who had normal initial venous lactatea (n=303, 64.7%) Patients who had elevated initial venous lactateb (n=165, 35.3%) p-valuec
Syncope, n (%) 11 (2.3) 6 (1.9) 5 (3.0) 0.53
Bright red blood per rectum, n (%) 73 (15.6) 55 (18.1) 18 (10.9) 0.04
Hematemesis, n (%) 82 (17.5) 40 (13.2) 42 (25.4) 0.001
Abdominal pain, n (%) 128 (27.3) 101 (33.3) 27 (16.3) <0.001
Altered mental status, n (%) 13 (2.8) 4 (1.3) 9 (5.4) 0.01
Ascites, n (%) 41 (8.7) 16 (5.3) 25 (15.1) <0.001
Heart rate, median (IQR), per minute 76 (67–86) 75 (67–85) 78 (68–90) 0.09
Systolic blood pressure, median (IQR), mmHg 122 (110–137) 122 (110–138) 121 (109–135) 0.39
Hemoglobin, median (IQR), g/dL 11.3 (8.8–13.6) 11.6 (9.1–13.8) 10.6 (8.3–13.1) 0.02
Platelet count, median (IQR), ×109/L 215 (157–293) 225 (168–299) 188 (126–287) 0.01
INR, median (IQR) 1.1 (1–1.5) 1.1 (1.0–1.3) 1.2 (1.1–1.7) <0.001
Creatinine, median (IQR), mg/dL 0.9 (0.8–1.3) 0.9 (0.8–1.2) 1.0 (0.8–1.5) 0.003
Presentation during daytime (7 am–7 pm), n (%) 334 (71.4) 211 (69.6) 123 (74.5) 0.26
ICU admission, n (%) 128 (27.3) 59 (19.5) 69 (41.8) <0.001
Endoscopy, n (%) 167 (35.7) 87 (28.7) 80 (48.5) <0.001
Medical therapy, n (%) 366 (78.2) 220 (72.6) 146 (88.5) <0.001
PRBC transfusion, n (%) 171 (36.5) 90 (29.7) 81 (49.1) <0.001
Length of hospital stay, median (IQR), days 3 (2–6) 3 (1–5) 4 (2–8) <0.001

Notes:

a

Normal venous lactate range 0.5–2.0 mmol/L.

b

Elevated venous lactate >2.0 mmol/L.

c

p-values cited compare patients with normal and elevated venous lactate on presentation. Bold values signify statistically significant p-values.

Abbreviations: IQR, interquartile range; INR, international normalized ratio; ICU, intensive care unit; PRBC, packed red blood cell.